TY  - JOUR
AU  - Caston, Juan J
AU  - Lacort-Peralta, Isabel
AU  - Martin-Davila, Pilar
AU  - Loeches, Belen
AU  - Tabares, Salvador
AU  - Temkin, Liz
AU  - Torre-Cisneros, Julian
AU  - Paño-Pardo, Jose R
PY  - 2017
DO  - 10.1016/j.ijid.2017.03.021
UR  - http://hdl.handle.net/10668/11071
T2  - International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
AB  - The primary objective was to describe clinical features, treatment and outcomes in patients with carbapenemase-producing Enterobacteriaceae (CPE) bacteremia. Additionally, patients treated with ceftazidime/avibactam (study group) were compared to the...
LA  - en
PB  - Elsevier
KW  - Bloodstream infections
KW  - Carbapenemase-producing Enterobacteriaceae
KW  - Ceftazidime-avibactam
KW  - Anti-bacterial agents
KW  - Azabicyclo compounds
KW  - Bacteremia
KW  - Bacterial proteins
KW  - Ceftazidime
KW  - Cohort studies
KW  - Drug therapy, combination
KW  - Enterobacteriaceae
KW  - Enterobacteriaceae infections
KW  - Female
KW  - Hematologic neoplasms
KW  - Humans
KW  - Male
KW  - Microbial sensitivity tests
KW  - Middle aged
KW  - Retrospective studies
KW  - Treatment outcome
KW  - beta-lactamases
TI  - Clinical efficacy of ceftazidime/avibactam versus other active agents for the treatment of bacteremia due to carbapenemase-producing Enterobacteriaceae in hematologic patients.
TY  - research article
VL  - 59
ER  -